Osmotics
Infrequently for reduction in IOP
-initial tx of acute/extreme IOP elev (angle-closure, secondary)
Most effective in short-term tx
Pre-operative
Osmotics
-MOA (2)
Lower IOP: incr osmotic gradient b/w blood and ocular fluids
-blood osmolality incr by ~20-30mOsm/L -> loss of water from eye to hyperosmostic plasma
Osmostic gradient b/w retina-choroid and vitreous causes water transfer -> reduction of vitreous volume
Osmotics ocular penetration
Produce less of an osmotic gradient than those that penetrate slowly/not at all
Enter aqueous rapidly, but slow penetration in avascular vitreous
Greatly incr with inflammation, congestion
Osmotics
-distribution in body fluids
Drugs restricted to ECF space (mannitol) have greater effect on blood osmolality
Less affected by drugs distributed in total body water (urea)
Osmotics concentration issues
Require larger volumes of solution
Decr blood osmolality
Osmotics dosage:
Total dose administered, weight of pt
IV bypasses GI tract = more rapid, greater osmotic gradient vs oral
Osmotics
-indications
Short-term acute IOP
Angle-closure
Aqueous misdirection
Certain secondary glaucs
Osmotics
-contraindications
Anuria
Severe dehydration
Acute pulmonary edema
Severe cardiac decompensation
Osmotics tx regimen
Flavoring, over ice
1-2 g/kg of body weight
Effect lasts 5-6 hrs
2-4 doses/day during short term use
Terminate IV when desired effect on IOP is reached
Store at room temp, higher [] may require slight warming
-crystals form
Should include filter
Osmotics
-SE
IOP rebound may be less common with glycerol and mannitol
-poor ocular penetration
Hyperglycemia with glycerol
Osmotics
-drug interactions
May compromise renal/CV status
-caution